Nectar Lifesciences’ API facility in Punjab received seven observations, including four critical, from European regulators. The pharma stock fell 5% on the BSE.
Nectar Lifesciences’ API facility in Punjab received seven observations, including four critical, from European regulators. The pharma stock fell 5% on the BSE.